Sun.Mar 17, 2024

article thumbnail

Keeping score: novel method might help differentiate 2 serious skin diseases

SCIENMAG: Medicine & Health

Your skin becomes red and spots filled with pus appear, so you visit a dermatologist. When these symptoms spread to the skin throughout the body, it is difficult for the physician to distinguish whether it is generalized pustular psoriasis (GPP) or acute generalized exanthematous pustulosis (AGEP), as both have similar symptoms.

Disease 87
article thumbnail

Contineum, a startup born from a Roche buyout, files for IPO

BioPharma Drive: Drug Pricing

The biotech, formed as a successor to a company Roche acquired in 2018, has two drugs in clinical testing for neurological and immune diseases.

Disease 80
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New tentative approval for Zydus Pharms drug empagliflozin;linagliptin;metformin hydrochloride

Drug Patent Watch

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.

article thumbnail

Coding Marvels: Navigating Dynamic Apex in Salesforce

Perficient: Drug Development

Aloha Trailblazers! Today we are going to understand and learn more about dynamic apex. As per Salesforce Documentation , Dynamic Apex enables developers to create more flexible applications. In simpler terms dynamic apex allows you to create generic code that could be reused along with multiple sObjects.Thus reducing the overhead of creating the block of code multiple times for multiple objects.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

New tentative approval for Sandoz Inc drug rifaximin

Drug Patent Watch

Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound.

Drugs 59
article thumbnail

Pharmaceutical companies with the most ‘New Chemical Entity’ drugs

Drug Patent Watch

Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs.